Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03767361Phase 1Completed
Phase 1, randomised trial of red blood cells in anemia of prematurity (AOP). Primary endpoints: malondialdehyde, total antioxidant capacity and 1 more. Started Jun 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03767361.